“On this week’s Tech Nation, Moira speaks with Dr. Greg Frost, the CEO of Exuma Biotech. He explains how gene therapy for cancer is currently a 6 to 8 week proposition, and requires the patient to undergo chemotherapy. Exuma’s aim is to reduce the time to 4 hours and eliminate the chemotherapy”
